Literature DB >> 23354677

DNA bacterial load in children with bacteremic pneumococcal community-acquired pneumonia.

S Esposito1, A Marchese, A E Tozzi, G A Rossi, L Da Dalt, G Bona, C Pelucchi, G C Schito, N Principi.   

Abstract

This study was conducted to evaluate the association between pneumococcal DNA load and parapneumonic pleural effusion (PPE) in children with community-acquired pneumonia. Bacterial load was quantified and related to the presence of PPE with or without empyema in 72 otherwise healthy children aged ≤5 years who were hospitalised because of radiographically confirmed CAP and showed a real-time polymerase chain reaction that was positive for Streptococcus pneumoniae. The proportion of children with a high bacterial load (i.e. ≥265 DNA copies/mL) was larger among the subjects with PPE than those without it. Multivariate analysis showed that a high bacterial load was significantly associated with PPE (OR 8.65; 95% CI 1.10-67.8 vs a bacterial load of <125 copies/mL). Children with infection due to pneumococcal serotype 19A were at highest risk of developing PPE (OR 7.44; 95% CI 1.10-50.4 vs all other typeable serotypes). The patients with CAP due to pneumococcal serotypes that are not included in the 13-valent conjugate vaccine (PCV13) were more frequently affected by PPE than those with infections associated with serotypes included in the vaccine, except for serotype 19A. Bacterial loads of ≥265 DNA copies/mL are significantly associated with PPE, and serotype 19A is significantly associated with a high bacterial load and the development of PPE. The mean bacterial load of the patients with empyema was higher than that of patients with simple PPE. Although further studies are required, it seems that serotypes not included in PCV13 can play a major role in causing a higher bacterial load and PPE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23354677     DOI: 10.1007/s10096-013-1821-0

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

Review 1.  Update on the causes, investigation and management of empyema in childhood.

Authors:  Woolf Walker; Robert Wheeler; Julian Legg
Journal:  Arch Dis Child       Date:  2010-08-24       Impact factor: 3.791

2.  National hospitalization trends for pediatric pneumonia and associated complications.

Authors:  Grace E Lee; Scott A Lorch; Seth Sheffler-Collins; Matthew P Kronman; Samir S Shah
Journal:  Pediatrics       Date:  2010-07-19       Impact factor: 7.124

3.  Bacteremic pneumococcal community-acquired pneumonia in children less than 5 years of age in Italy.

Authors:  Susanna Esposito; Anna Marchese; Alberto E Tozzi; Giovanni A Rossi; Liviana Da Dalt; Gianni Bona; Claudio Pelucchi; Gian Carlo Schito; Nicola Principi
Journal:  Pediatr Infect Dis J       Date:  2012-07       Impact factor: 2.129

Review 4.  What is different about serotype 1 pneumococci?

Authors:  Neil D Ritchie; Tim J Mitchell; Tom J Evans
Journal:  Future Microbiol       Date:  2012-01       Impact factor: 3.165

5.  Real-time PCR assays for the detection and quantification of Streptococcus pneumoniae.

Authors:  Hee Kuk Park; Hee Joong Lee; Hee Jung Lee; Wonyong Kim
Journal:  FEMS Microbiol Lett       Date:  2010-06-18       Impact factor: 2.742

6.  Molecular detection methods and serotyping performed directly on clinical samples improve diagnostic sensitivity and reveal increased incidence of invasive disease by Streptococcus pneumoniae in Italian children.

Authors:  Chiara Azzari; Maria Moriondo; Giuseppe Indolfi; Cristina Massai; Laura Becciolini; Maurizio de Martino; Massimo Resti
Journal:  J Med Microbiol       Date:  2008-10       Impact factor: 2.472

7.  Detection and quantitation of bacteremia in childhood.

Authors:  M Santosham; E R Moxon
Journal:  J Pediatr       Date:  1977-11       Impact factor: 4.406

8.  Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis.

Authors:  Carlos G Grijalva; J Pekka Nuorti; Patrick G Arbogast; Stacey W Martin; Kathryn M Edwards; Marie R Griffin
Journal:  Lancet       Date:  2007-04-07       Impact factor: 79.321

9.  Effect of serotype on focus and mortality of invasive pneumococcal disease: coverage of different vaccines and insight into non-vaccine serotypes.

Authors:  Albert Jan van Hoek; Nick Andrews; Pauline A Waight; Robert George; Elizabeth Miller
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

10.  Bacteriaemia and prognosis in lobar pneumonia: the results of quantitative blood culture in pneumococcus pneumonia.

Authors:  J B LANDSMAN
Journal:  Glasgow Med J       Date:  1952-02
View more
  5 in total

1.  Diagnostic value of serum pneumococcal DNA load during invasive pneumococcal infections.

Authors:  A J H Cremers; F Hagen; P W M Hermans; J F Meis; G Ferwerda
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-01-22       Impact factor: 3.267

2.  Risk factors for pneumococcal endocarditis.

Authors:  T J Marrie; G J Tyrrell; S R Majumdar; D T Eurich
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-24       Impact factor: 3.267

Review 3.  Pneumococcal empyema and complicated pneumonias: global trends in incidence, prevalence, and serotype epidemiology.

Authors:  M A Fletcher; H-J Schmitt; M Syrochkina; G Sylvester
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-02-23       Impact factor: 3.267

4.  Heme Oxygenase-1 Deficiency Diminishes Methicillin-Resistant Staphylococcus aureus Clearance Due to Reduced TLR9 Expression in Pleural Mesothelial Cells.

Authors:  Satindra Gahlot; Najmunnisa Nasreen; Judith A Johnson; Steven A Sahn; Kamal A Mohammed
Journal:  PLoS One       Date:  2017-01-04       Impact factor: 3.240

5.  Association between semi-quantitative microbial load and respiratory symptoms among Thai military recruits: a prospective cohort study.

Authors:  Clarence C Tam; Vittoria Offeddu; Kathryn B Anderson; Alden L Weg; Louis R Macareo; Damon W Ellison; Ram Rangsin; Stefan Fernandez; Robert V Gibbons; In-Kyu Yoon; Sriluck Simasathien
Journal:  BMC Infect Dis       Date:  2018-09-14       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.